However, we unexpectedly found that until now there was no direct evidence which proved that it was ALDH1A3 that was a major contributor to ALDH activity and also a key driver in triggering mesenchymal transformation in GBM, although there were some studies that might mention this. This evidence concerns the gene ALDH1A3 and glioblastoma.